Every 10-Q that Veeva Systems Inc. (VEEV) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow VEEV and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full VEEV filings page.
Veeva Systems Inc. (VEEV) delivered strong growth for the quarter ended July 31, 2026. Total revenues rose to $928 million, up 18% year over year, with subscription revenues of $767 million (up 16%) and professional services and other revenues of $161 million (up 24%). GAAP operating income increased to $275 million and net income to $273 million, versus $196 million and $200 million a year earlier. Diluted EPS was $1.66, compared with $1.19.
Gross margin held at 75%, while GAAP general and administrative expense declined due to prior-year litigation settlement charges. Veeva generated $1.37 billion in operating cash flow in the first six months and ended the period with $7.2 billion in cash, cash equivalents, and short-term investments and no debt. The company acquired Ostro for $90 million and repurchased 2.66 million shares for about $467 million, leaving $1.4 billion available under its two-year, $2 billion buyback authorization. Growth was broad-based across geographies and both Commercial and R&D and Quality Solutions, with non-GAAP operating income of $416 million and non-GAAP net income of $387 million for the quarter.
Veeva Systems reported strong quarterly growth, with total revenues of $882,948,000 for the three months ended April 30, 2026, up 16% year over year. Subscription revenue reached $730,175,000 and continued to represent 83% of total revenue, reflecting broad demand across Commercial and R&D and Quality solutions.
GAAP net income rose to $260,936,000 from $228,190,000, and diluted EPS increased to $1.57 from $1.37. Gross margin remained high at 75%, with GAAP operating income of $273,112,000 and non-GAAP operating income of $395,376,000. Non-GAAP diluted EPS was $2.24.
Operating cash flow was very strong at $1,127,116,000, supporting cash, cash equivalents, and short-term investments totaling $7.3 billion as of April 30, 2026. The company acquired Ostro for $90 million to expand its AI-driven patient and doctor engagement capabilities and repurchased 1,255,029 shares for approximately $221,100,000 under a $2 billion, two-year share repurchase program.
Veeva Systems (VEEV) reported strong quarterly growth for the three months ended October 31, 2025. Total revenue rose 16% to $811.2 million from $699.2 million, driven by a 17% increase in subscription services revenue to $682.5 million and 9% growth in professional services to $128.7 million.
Net income increased to $236.2 million from $185.8 million, with diluted EPS rising to $1.40 from $1.13. Gross margin held at 75%, while operating income grew to $240.9 million from $181.4 million. Revenue growth was broad-based across Commercial and R&D Solutions and all major regions, with R&D Solutions contributing slightly more than half of total revenue.
Veeva ended the period with $1.66 billion in cash and cash equivalents and $4.98 billion in short-term investments, supporting a strong net cash position. Operating cash flow for the nine months reached $1.31 billion, up from $1.02 billion a year earlier, reflecting profitable growth and high subscription visibility.
Veeva Systems (VEEV) reports interim condensed consolidated results and disclosures for the quarter ended July 31, 2025. The company held $6.4 billion in cash, cash equivalents, and short-term investments and generated $1,116 million of net cash from operating activities for the six months ended July 31, 2025 versus $856 million a year earlier, reflecting stronger collections and tax impacts from recent U.S. tax legislation.
Goodwill remained $440 million. Short-term liquidity exposures include a fixed-income portfolio sensitive to interest rates: a 100-basis-point immediate rise would reduce market value by $72 million. Unbilled accounts receivable totaled $50 million as of July 31, 2025 (receivables $42 million; contract assets $8 million). The company accrued approximately $31 million for success fees to law firms following settlement of the IQVIA litigations on August 13, 2025, under which neither party pays damages and claims were dismissed. Stock-based compensation had $541 million (options) and $180 million (RSUs) of unrecognized cost.